Bangkok Dusit Medical Services PCL (BDUUF)
0.7744
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Bangkok Dusit Medical Services Revenue (Quarterly): 745.46M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 745.46M |
| December 31, 2023 | 736.34M |
| September 30, 2023 | 748.56M |
| June 30, 2023 | 698.84M |
| March 31, 2023 | 709.12M |
| December 31, 2022 | 645.90M |
| September 30, 2022 | 650.62M |
| June 30, 2022 | 633.24M |
| March 31, 2022 | 695.21M |
| December 31, 2021 | 646.10M |
| September 30, 2021 | 596.48M |
| June 30, 2021 | 547.43M |
| March 31, 2021 | 528.37M |
| December 31, 2020 | 582.43M |
| September 30, 2020 | 533.38M |
| June 30, 2020 | 431.45M |
| March 31, 2020 | 631.94M |
| December 31, 2019 | 697.54M |
| September 30, 2019 | 703.73M |
| June 30, 2019 | 614.27M |
| March 31, 2019 | 648.74M |
| December 31, 2018 | 590.49M |
| September 30, 2018 | 610.02M |
| June 30, 2018 | 571.80M |
| March 31, 2018 | 619.98M |
| Date | Value |
|---|---|
| December 31, 2017 | 562.48M |
| September 30, 2017 | 577.85M |
| June 30, 2017 | 493.29M |
| March 31, 2017 | 489.10M |
| December 31, 2016 | 488.56M |
| September 30, 2016 | 515.82M |
| June 30, 2016 | 438.26M |
| March 31, 2016 | 478.88M |
| December 31, 2015 | 461.89M |
| September 30, 2015 | 455.21M |
| June 30, 2015 | 440.72M |
| March 31, 2015 | 475.69M |
| December 31, 2014 | 453.29M |
| September 30, 2014 | 443.08M |
| June 30, 2014 | 401.02M |
| March 31, 2014 | 424.57M |
| December 31, 2013 | 410.57M |
| September 30, 2013 | 423.56M |
| June 30, 2013 | 396.26M |
| March 31, 2013 | 410.90M |
| December 31, 2012 | 386.48M |
| September 30, 2012 | 378.04M |
| June 30, 2012 | 340.75M |
| March 31, 2012 | 353.15M |
| December 31, 2011 | 338.66M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
431.45M
Minimum
Jun 2020
748.56M
Maximum
Sep 2023
638.82M
Average
646.00M
Median
Revenue (Quarterly) Benchmarks
| Bumrungrad Hospital PCL | 183.12M |
| NewGenIvf Group Ltd | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.04M |
| IGC Pharma Inc | 0.204M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 114.12M |
| Total Expenses (Quarterly) | 596.95M |
| EPS Diluted (Quarterly) | 0.0073 |
| Enterprise Value | 12.30B |
| Gross Profit Margin (Quarterly) | 37.11% |
| Profit Margin (Quarterly) | 15.31% |
| Earnings Yield | 3.40% |
| Operating Earnings Yield | 4.51% |
| Normalized Earnings Yield | 3.390 |